a significant trendP<0.0001
The dose-response relationship was clear: the risk of spinal pain gradually increased with higher quartile groups, and the risk in the Q3 group was 2.58 times that of the Q1 group (reference group) in Model 2, with a significant trend test (all P<0.0001).